Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,808 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05838183Recruiting
Test treatment in people with lung disease and sleep apnea
This trial is studying how a treatment may work for adults who have interstitial lung disease or obstructive sleep apnea. It likely involves sleep testing so the team can measure breathing and sleep patterns.
TianjinAges 18–80 - NCT06963320RecruitingPhase 2
Preventing blood clots after knee replacement with H001
This trial tests whether an experimental capsule (H001) can prevent dangerous blood clots after knee replacement surgery. It is for people who are scheduled for a first-time total knee replacement and are willing to take the study drug instead of standard blood thinners.
Shanghai, Shanghai MunicipalityAges 18–74 - NCT05954130Enrolling by invitation
Sexual health education for early pregnancy
This study tests whether a web-based course about sexual health during pregnancy can improve your sexual wellbeing. It focuses on people who are in their first trimester and have not already received similar sexual health education.
AdanaAges 18–35 - NCT03206372Recruiting
Study of blood clot risk during hormone use in families
This study looks at what increases the risk of deep vein thrombosis or a lung blood clot (venous thromboembolism) in women who are using hormones. Researchers compare close family members to understand inherited risk and hormone-related triggers, which may help with prevention in the future.
BrestAges 16 years+ - NCT06877195Recruiting
Vein graft support mesh for bypass surgery
This trial tests a mesh wrap that supports the vein grafts used in bypass surgery. It may help those grafts stay open longer, especially for the right side of the heart.
Roma, RomaAges Any age - NCT06745687Recruiting
BCMA/CD3 antibody for high-risk smoldering myeloma
This trial tests a new medicine called a BCMA/CD3 bispecific antibody for people with a very early form of multiple myeloma called high-risk smoldering myeloma. The goal is to see if this treatment can stop the disease from getting worse.
TianjinAges 18–78 - NCT07189676Recruiting
Healthy eating study for adults with metabolic issues
This study tests how eating sustainably can improve heart and metabolic health. It looks at whether a diet with more plant-based foods and less red meat can help people with conditions like high blood pressure or prediabetes.
Copenhagen, CopenhagenAges 45–70 - NCT07265596RecruitingPhase 2
Brain Scan Study for Early Parkinson's Disease
This trial uses a special brain scan (PET scan) to look at early changes in people who have early signs of Parkinson's disease. The goal is to learn more about how Parkinson's develops over time.
New Haven, ConnecticutAges 18 years+ - NCT06917703Enrolling by invitation
Mobile health program for first-time pregnant women
This study tests a mobile health program to help first-time pregnant women manage weight and blood sugar. The program uses your phone to provide support and track data, aiming to support a healthy pregnancy.
Taipei, TaiwanAges 18–50 - NCT03331380Recruiting
Low-energy MRI study for people with or without heart disease
This study tests a special MRI method that uses lower energy exposure. It aims to improve how well researchers can scan the heart and other organs while keeping the scan as safe and comfortable as possible.
Bethesda, MarylandAges 18–100 - NCT06561620RecruitingPhase 4
Befotertinib after surgery for early-stage lung cancer
This trial tests a pill called befortinib for people with early-stage lung cancer who have had surgery. It aims to lower the chance of the cancer coming back. You might qualify if your tumor had certain high-risk features and you still have cancer DNA in your blood after surgery.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06942611Recruiting
Electrical brain stimulation for chronic pain from nerve inflammation
This study tests a noninvasive brain stimulation technique (transcranial electrical stimulation) to see if it can reduce chronic pain in people with conditions like multiple sclerosis or neuromyelitis optica. It aims to offer a new, drug-free option for pain relief without major side effects.
BeijingAges 18–65 - NCT07266467RecruitingPhase 4
Preventing CMV After First Kidney Transplant
This trial tests a new medicine, Leymovir, against a standard one, Valganciclovir, to prevent a common virus infection (CMV) after a first kidney transplant. It may help you avoid CMV-related illness.
Xi'an, ShaanxiAges 18 years+ - NCT07612553Recruiting
Imaging study of calcium buildup on heart valves
This research compares two types of heart imaging scans to better see calcium deposits on the mitral valve (a valve in your heart). Researchers hope this helps doctors plan valve procedures more safely and accurately.
Milan, MilanAges 18 years+ - NCT05620706Recruiting
GPC-3 CAR-T for advanced liver cancer
This trial tests CAR-T cell therapy (immune cells changed to target GPC-3) for advanced hepatocellular carcinoma, especially when standard treatments no longer work or you cannot tolerate them. If eligible, the goal is to shrink tumors and help you live longer with improved cancer control.
Shenzhen, GuangdongAges 40–70 - NCT06939374Recruiting
Freezing heart arteries to stabilize high-risk plaques
This study tests a special cooling balloon to freeze and stabilize dangerous plaques in heart arteries that are not the main cause of your current symptoms. It aims to prevent future heart attacks.
AalstAges 18 years+ - NCT06883149RecruitingPhase 1
Combination treatment for solid tumors that stopped responding to prior therapy
This trial tests a new combination of two drugs (PIN plus an anti-PD1 immunotherapy) for people with advanced solid tumors that either did not respond to standard treatment or have tumor types known to have low response to immunotherapy, like liver cancer. The goal is to see if this combination can help shrink or control the cancer.
Beijing, Beijing MunicipalityAges 18–75 - NCT06928844Recruiting
Low dose progesterone injection for ovulation
This trial tests whether a low dose of progesterone (a hormone) can help trigger ovulation in women who have trouble getting pregnant. It may offer a new option for women with infertility.
CairoAges 20–35 - NCT06919562Recruiting
Better stent placement using imaging and newer scaffolds
This trial tests if using advanced imaging (like OCT or IVUS) to guide placement of a newer type of stent (bioresorbable scaffold) can reduce future stent problems. It is for people with stable coronary artery disease who need a stent in a main heart artery.
DordrechtAges 18 years+ - NCT03688295RecruitingPhase 3
Testing the best antibiotic length after laparoscopic appendix surgery
This study compares whether you need antibiotics after laparoscopic surgery for a complicated, “localized” appendix infection. It aims to find the safest, most effective antibiotic approach after surgery.
AmiensAges 18 years+ - NCT06321289RecruitingPhase 1/Phase 2
Donor T cell therapy for B-cell lymphoma
This trial tests a new type of therapy where specially designed donor T cells target your lymphoma. It's for people with certain B-cell non-Hodgkin lymphomas that have not responded to or returned after standard treatments. You might join if you meet the health and disease criteria listed below.
Beijing, Beijing MunicipalityAges 18–75 - NCT06906835Recruiting
Comparing two blood tests to guide iron treatment in dialysis patients
This trial tests whether a new blood test (reticulocyte hemoglobin) is better than the usual iron test (transferrin saturation) for guiding when to give iron to people on dialysis. If you have anemia (low red blood cells) from kidney disease, this study may help doctors find the best way to treat your iron levels.
Pathumwan, BangkokAges 18–80 - NCT06906250Recruiting
European registry for leg vein blood clots
This trial is a registry (a database study) that tracks people with blood clots in the large veins of their legs or abdomen. It does not test any new drug or treatment, but helps doctors learn more about these conditions.
Marseille, FranceAges 18 years+ - NCT03717792Recruiting
Check how doctors follow up vascular liver disease
This study focuses on people who have vascular liver disease and aims to evaluate follow-up care and non-invasive ways to assess it. It may help improve how safely and accurately doctors monitor your liver without invasive procedures.
BonnAges 18–100
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,808 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.